- Home
- HCAT vs PRQR Comparison
HCAT vs PRQR Comparison
Compare HCAT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAT
- PRQR
- Stock Information
- Founded
- HCAT 2008
- PRQR 2012
- Country
- HCAT United States
- PRQR Netherlands
- Employees
- HCAT N/A
- PRQR N/A
- Industry
- HCAT Computer Software: Programming Data Processing
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- HCAT Technology
- PRQR Health Care
- Exchange
- HCAT Nasdaq
- PRQR Nasdaq
- Market Cap
- HCAT 259.8M
- PRQR 179.1M
- IPO Year
- HCAT 2019
- PRQR 2014
- Fundamental
- Price
- HCAT $4.06
- PRQR $2.18
- Analyst Decision
- HCAT Buy
- PRQR Strong Buy
- Analyst Count
- HCAT 11
- PRQR 8
- Target Price
- HCAT $8.00
- PRQR $8.88
- AVG Volume (30 Days)
- HCAT 660.7K
- PRQR 371.0K
- Earning Date
- HCAT 08-06-2025
- PRQR 08-07-2025
- Dividend Yield
- HCAT N/A
- PRQR N/A
- EPS Growth
- HCAT N/A
- PRQR N/A
- EPS
- HCAT N/A
- PRQR N/A
- Revenue
- HCAT $311,274,000.00
- PRQR $21,212,711.00
- Revenue This Year
- HCAT $11.23
- PRQR N/A
- Revenue Next Year
- HCAT $9.71
- PRQR N/A
- P/E Ratio
- HCAT N/A
- PRQR N/A
- Revenue Growth
- HCAT 4.88
- PRQR 85.91
- 52 Week Low
- HCAT $3.49
- PRQR $1.07
- 52 Week High
- HCAT $9.24
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- HCAT 57.35
- PRQR 65.20
- Support Level
- HCAT $3.73
- PRQR $1.89
- Resistance Level
- HCAT $4.13
- PRQR $2.54
- Average True Range (ATR)
- HCAT 0.22
- PRQR 0.13
- MACD
- HCAT 0.04
- PRQR 0.01
- Stochastic Oscillator
- HCAT 88.89
- PRQR 39.85
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.